Profile | GDS4284 / 215358_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 904.841 | 73 |
GSM687648 | Patient 402 control | 688.864 | 68 |
GSM687653 | Patient 403 control | 1172.09 | 77 |
GSM687658 | Patient 404 control | 637.094 | 67 |
GSM687663 | Patient 411 control | 894.289 | 72 |
GSM687668 | Patient 422 control | 586.518 | 66 |
GSM687673 | Patient 424 control | 596.536 | 66 |
GSM687678 | Patient 425 control | 666.157 | 67 |
GSM687683 | Patient 427 control | 665.767 | 67 |
GSM687688 | Patient 428 control | 350.472 | 58 |
GSM687695 | Patient 441 control | 731.396 | 70 |
GSM687699 | Patient 443 control | 399.634 | 59 |
GSM687704 | Patient 444 control | 1666.29 | 81 |
GSM687707 | Patient 448 control | 475.055 | 62 |
GSM687712 | Patient 449 control | 436.602 | 61 |
GSM687719 | Patient 450 control | 758.885 | 69 |
GSM687724 | Patient 451 control | 1208.33 | 77 |
GSM687728 | Patient 452 control | 552.731 | 65 |
GSM687646 | Patient 401 treated 24h | 832.527 | 71 |
GSM687649 | Patient 402 treated 24h | 683.898 | 68 |
GSM687665 | Patient 411 treated 24h | 747.237 | 69 |
GSM687651 | Patient 402 treated 4 weeks | 608.093 | 66 |
GSM687667 | Patient 411 treated 4 weeks | 785.234 | 70 |
GSM687670 | Patient 422 treated 24h | 662.469 | 67 |
GSM687671 | Patient 422 treated 4 weeks | 555.698 | 65 |
GSM687654 | Patient 403 treated 24h | 1219.98 | 77 |
GSM687675 | Patient 424 treated 24h | 574.832 | 65 |
GSM687685 | Patient 427 treated 24h | 478.638 | 63 |
GSM687656 | Patient 403 treated 4 weeks | 625.302 | 67 |
GSM687677 | Patient 424 treated 4 weeks | 796.581 | 70 |
GSM687687 | Patient 427 treated 4 weeks | 670.573 | 68 |
GSM687692 | Patient 428 treated 4h | 376.004 | 59 |
GSM687716 | Patient 449 treated 4h | 475.524 | 63 |
GSM687722 | Patient 450 treated 4h | 780.345 | 70 |
GSM687680 | Patient 425 treated 24h | 954.934 | 73 |
GSM687690 | Patient 428 treated 24h | 447.31 | 63 |
GSM687700 | Patient 443 treated 24h | 489.762 | 60 |
GSM687705 | Patient 444 treated 24h | 1662.98 | 81 |
GSM687714 | Patient 449 treated 24h | 613.557 | 67 |
GSM687721 | Patient 450 treated 24h | 594.986 | 65 |
GSM687682 | Patient 425 treated 4 weeks | 741.352 | 70 |
GSM687694 | Patient 428 treated 4 weeks | 474.023 | 63 |
GSM687702 | Patient 443 treated 4 weeks | 591.754 | 65 |
GSM687718 | Patient 449 treated 4 weeks | 403.856 | 61 |
GSM687723 | Patient 450 treated 4 weeks | 721.442 | 69 |
GSM687661 | Patient 404 treated 4h | 635.81 | 67 |
GSM687710 | Patient 448 treated 4h | 502.6 | 64 |
GSM687726 | Patient 451 treated 4h | 857.288 | 72 |
GSM687730 | Patient 452 treated 4h | 1799.38 | 84 |
GSM687660 | Patient 404 treated 24h | 622.487 | 68 |
GSM687697 | Patient 441 treated 24h | 292.983 | 51 |
GSM687709 | Patient 448 treated 24h | 870.12 | 72 |
GSM687725 | Patient 451 treated 24h | 1044.97 | 75 |
GSM687729 | Patient 452 treated 24h | 567.811 | 66 |
GSM687727 | Patient 451 treated 4 weeks | 1256.15 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 454.733 | 61 |